Microlaparoscopic Robotic Surgeries Now Cleared on TransEnterix Senhance System

TransEnterix, the maker of the Senhance robotic surgical system, won FDA clearance for its new 3 millimeter line of instruments, as well as some more 5 mm instruments.

At only 3 mm in diameter, the new instruments make it possible to use the Senhance system for microlaparoscopic surgeries with incisions so small that, once healed, are nearly invisible.

“Utilizing 3 millimeter micro instruments on a robotic system represents a new advancement in reducing the invasiveness of many surgeries,” in a published statement said Dr. Steven D. McCarus, MD, FACOG, Chief of Gynecologic Surgery at Florida Hospital Celebration Health. “Patients find such small incisions to be virtually scarless and cosmetically desirable. Surgeons may find that using such tiny instruments with the precision and control of a digital interface makes microlaparoscopy a preferred option to treat more conditions.”